WallStSmart
NRXS

Neuraxis, Inc.

NYSE MKT: NRXS · HEALTHCARE · BIOTECHNOLOGY

$7.44
-2.23% today

Updated 2026-04-29

Market cap
$93.54M
P/E ratio
P/S ratio
26.21x
EPS (TTM)
$-0.95
Dividend yield
52W range
$2 – $8
Volume
0.2M

Neuraxis, Inc. (NRXS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+34.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.6%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+9.0%
2026-03-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-14$0.00+100.0%$6.99$7.00+0.1%
2026-03-19$-0.10+54.0%$6.99$7.62+9.0%
2025-11-11$-0.24+0.0%$2.56$2.60+1.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.24$0.00+100.0%
2025-12-31$-0.22$-0.10+54.0%$968127.00+27.2%
2025-09-30$-0.24$-0.24+0.0%$811414.00+21.7%
2025-06-30$-0.19$-0.22-15.8%$894086.00+46.2%
2025-03-31$-0.24$-0.33-37.5%$895655.00+38.5%
2024-12-31$0.04$-0.21-612.5%$761165.00+43.2%
2024-09-30$-0.25$666625.00+39.6%
2024-06-30$-0.05$-0.42-743.2%$611500.00
2024-03-31$-0.10$-0.82-716.3%$646635.00
2023-12-31$-0.15$-0.25-69.8%$531459.00
2023-09-30$-0.17$-1.35-694.1%$477460.00

Frequently asked questions

Has Neuraxis, Inc. beaten earnings estimates?
Neuraxis, Inc. has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +34.5% over the last 4 quarters.
How does NRXS stock react to earnings?
NRXS stock has moved an average of +3.6% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.